Amedeo Smart

Free Medical Literature Service

 

Amedeo

Hypersensitivity Reaction
  Free Subscription

Articles published in
Eur J Dermatol
    June 2026
  1. YANG J, Wang G, Zhang Y, Zheng R, et al
    Novel insights into the role of microRNAs in atopic dermatitis and psoriasis: diagnostic and therapeutic aspects.
    Eur J Dermatol. 2026;36:235-247.
    >> Share

  2. TORRES-BETATO F, Arnau AMG, Spertino J
    Efficacy, safety, and clinical use of second-generation antihistamines for chronic spontaneous urticaria: a comprehensive review.
    Eur J Dermatol. 2026;36:229-234.
    >> Share

    April 2026
  3. TAKAHASHI Y, Hagino T, Uchiyama A, Saeki H, et al
    Effectiveness, biomarker transition, and safety of 48-week tralokinumab treatment for atopic dermatitis: real-world analyses stratified by age groups (15-17, 18-64, and >/= 65 years).
    Eur J Dermatol. 2026;36:156-165.
    >> Share

    February 2026
  4. KIM J, Pak K, Lee J, Shin K, et al
    Improvement of depressive symptoms in patients with severe atopic dermatitis treated with dupilumab: an open-label trial validated using the Beck depression inventory, Hamilton depression rating scale measures, and 18F-fluorodeoxyglucose positron emis
    Eur J Dermatol. 2026;36:73-75.
    >> Share

  5. UGAJIN T, Yamamoto-Murata M
    Onset of furosemide-triggered bullous pemphigoid, possibly induced by CD8-positive T cell-mediated hypersensitivity reactions to drug and ultraviolet exposure.
    Eur J Dermatol. 2026;36:68-70.
    >> Share

    December 2025
  6. KOMATSU-FUJII T, Cho R, Nomiyama T, Yamamoto Y, et al
    Clinical outcome of alopecia areata in patients with atopic dermatitis treated with dupilumab combined with topical immunotherapy: a case series.
    Eur J Dermatol. 2025;35:519-526.
    >> Share

    October 2025
  7. TOYOSHIMA M, Nakaoji K, Hamada K, Yamanaka A, et al
    Analysis of skin aging patterns using a facial imaging system in atopic dermatitis patients of 20-34 years old.
    Eur J Dermatol. 2025;35:424-426.
    >> Share

    June 2025
  8. UCHIYAMA A, Ishikawa M, Kosaka K, Motegi SI, et al
    Effectiveness and safety of dupilumab in Japanese paediatric patients with atopic dermatitis: a multiple-centre retrospective study in a real-life setting in Gunma Prefecture.
    Eur J Dermatol. 2025;35:250-252.
    >> Share

  9. MINAKAWA F, Yanagida N, Sugiyama S, Toi Y, et al
    Differences in the management of toxic epidermal necrolysis related and unrelated to immune checkpoint inhibitors.
    Eur J Dermatol. 2025;35:224-229.
    >> Share

    April 2025
  10. KATO M, Igawa K, Ando Y, Miyamoto M, et al
    A paediatric case of severe atopic dermatitis with prurigo nodularis successfully treated with nemolizumab as second-line therapy.
    Eur J Dermatol. 2025;35:131-132.
    >> Share

  11. ANDELIC M, Groen SS, Holm JG, Egeberg A, et al
    A novel biomarker of type VII collagen degradation increases in patients with atopic dermatitis and decreases upon treatment with immunosuppressants.
    Eur J Dermatol. 2025;35:91-97.
    >> Share

    February 2025
  12. BERNARDO D, Alvarenga JM, Torres T
    Effectiveness and safety of dupilumab in adults with moderate-to-severe atopic dermatitis previously treated with JAK inhibitors.
    Eur J Dermatol. 2025;35:64-65.
    >> Share

  13. CHO E, Kim J, Kang B, Liu K, et al
    Skin condition and barrier function in individuals with a history of atopic dermatitis.
    Eur J Dermatol. 2025;35:16-24.
    >> Share

    December 2024
  14. SUZUKI Y, Fujiwara M, Takeshita H, Namiki T, et al
    Avoidable anaphylactic shock due to chlorhexidine gluconate in the oral cavity.
    Eur J Dermatol. 2024;34:681-682.
    >> Share

  15. DEZOTEUX F, Staumont-Salle D
    DRESS (drug reaction with eosinophilia and systemic symptoms): a possible prolonged course with sequelae.
    Eur J Dermatol. 2024;34:587-594.
    >> Share

    October 2024
  16. REYNAUD V, Dege T, Byrne N, Garcia-Piqueras P, et al
    Journal club: Biomarkers for atopic dermatitis: current use and perspectives.
    Eur J Dermatol. 2024;34:567-569.
    >> Share

  17. FREITAS E, Yilmaz O, Torres T
    Effectiveness and tolerance of tralokinumab after failure with dupilumab and baricitinib in a patient with atopic dermatitis.
    Eur J Dermatol. 2024;34:551-553.
    >> Share

  18. IKEZAWA S, Yokoyama E, Urakami H, Takigawa M, et al
    A case of anaphylaxis to kumquat (Citrus japonica).
    Eur J Dermatol. 2024;34:539-541.
    >> Share

  19. HAGINO T, Onda M, Saeki H, Fujimoto E, et al
    Effectiveness and safety of tralokinumab treatment for moderate-to-severe atopic dermatitis in real-world clinical practice in Japan.
    Eur J Dermatol. 2024;34:525-532.
    >> Share

  20. METSINI A, Ryen L, Montgomery S, Svensson A, et al
    Healthcare visits, patterns of treatment, and related costs in children with controlled and uncontrolled atopic dermatitis in Sweden.
    Eur J Dermatol. 2024;34:509-516.
    >> Share

    August 2024
  21. NEUBAUER C, Kragl M, Braun T, Filipek P, et al
    An oil-in-water emulsion containing a combination of ginger extract and synthetic cannabidiol with potent in vitro anti-inflammatory effects alleviates symptoms of atopic dermatitis in a clinical trial.
    Eur J Dermatol. 2024;34:416-424.
    >> Share

  22. URENA-PANIEGO C, Sanabria-De-La-Torre R, Ramirez-Munoz A, Soto-Moreno A, et al
    Response to biological drugs and JAK inhibitors following cyclosporine in patients with atopic dermatitis.
    Eur J Dermatol. 2024;34:409-415.
    >> Share

  23. SOKOLOVSKIS A, Lapina L, Lauva A, Papirte S, et al
    Epidemiological and clinical characteristics of adult patients with chronic spontaneous urticaria in Latvia: insights from a two-centre study.
    Eur J Dermatol. 2024;34:398-408.
    >> Share

  24. GAMBICHLER T, Ardabili L, Domin B, Susok L, et al
    Predictors of disease severity, length of hospitalization, and recurrence in inpatients with single-organ cutaneous small vessel vasculitis.
    Eur J Dermatol. 2024;34:378-383.
    >> Share

  25. ZHOU X, Su J, Zhang CL, Dai H, et al
    Decreased expression of galectin-3 in the epidermis of psoriasis patients.
    Eur J Dermatol. 2024;34:371-377.
    >> Share

  26. BAKAR J, Michael-Jubeli R, Salmon M, Lancelot C, et al
    Effect of Th2 cytokines on ceramide subclasses based on a model of reconstructed human epidermis.
    Eur J Dermatol. 2024;34:361-370.
    >> Share

    June 2024
  27. GAMBICHLER T, Sandersfeld MH, Schaller J, Wiech T, et al
    Adult Henoch-Schonlein purpura complicated by IgA-nephritis in a patient with mantle cell lymphoma and Graves disease.
    Eur J Dermatol. 2024;34:318-320.
    >> Share

  28. FOTI C, Calianno G, Sbarra G, Pisani MC, et al
    Crusted scabies diagnosed in an atopic patient during treatment with upadacitinib.
    Eur J Dermatol. 2024;34:311-312.
    >> Share

  29. YOSHIDA S, Shiraishi K, Yatsuzuka K, Kohri N, et al
    Effects of hot bath therapy on cholinergic urticaria with hypohidrosis or anhidrosis.
    Eur J Dermatol. 2024;34:271-275.
    >> Share

    February 2024
  30. FUKUDA H, Aoki S, Harada Y, Matsumoto C, et al
    A case of acute generalized exanthematous pustulosis caused by eperisone hydrochloride.
    Eur J Dermatol. 2024;34:97-98.
    >> Share

  31. OUNI B, Mansour K, Sassi M, Sriha B, et al
    Silodosin-induced leukocytoclastic vasculitis: a first case report.
    Eur J Dermatol. 2024;34:92-93.
    >> Share

  32. GIMENEZ-ARNAU AM, Salman A, Podder I
    Biomarkers to predict therapeutic response in chronic spontaneous urticaria: a review.
    Eur J Dermatol. 2024;34:3-12.
    >> Share

    December 2023
  33. DE GREEF A, Ghislain PD, Baeck M
    Prolonged real-life experience with baricitinib in patients with moderate-to-severe atopic dermatitis.
    Eur J Dermatol. 2023;33:707-709.
    >> Share

  34. NISHIYORI R, Sakai T, Nishida H, Hatano Y, et al
    An unusual case of immediate and delayed hypersensitivity to wasp stings.
    Eur J Dermatol. 2023;33:701-703.
    >> Share

  35. TSAI YC, Tsai TF
    Successful treatment of atopic dermatitis by switching from upadacitinib to abrocitinib: a case report.
    Eur J Dermatol. 2023;33:699-701.
    >> Share

  36. MIYAWAKI K, Nakashima C, Otsuka A
    Real-world effectiveness and safety of nemolizumab for the treatment of atopic dermatitis in Japanese patients: a single-centre retrospective study.
    Eur J Dermatol. 2023;33:691-692.
    >> Share

  37. LAMOLET M, Barbarin C, Renaud O, Sahin Y, et al
    Acceleration of cutaneous T-cell lymphoma mistaken for atopic dermatitis following JAK inhibitor use.
    Eur J Dermatol. 2023;33:686-687.
    >> Share

  38. COHEN E, Lheure C, Ingen-Housz-Oro S, Hotz C, et al
    Which first-line treatment for cutaneous sarcoidosis? A retrospective study of 120 patients.
    Eur J Dermatol. 2023;33:680-685.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016